Plasma Leptin Levels and Risk of Breast Cancer in Premenopausal Women
Open Access
- 1 September 2011
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 4 (9) , 1449-1456
Abstract
Body mass index (BMI) is inversely related to the risk of premenopausal breast cancer, but the underlying biological mechanisms of this association are poorly understood. Leptin, a peptide hormone produced primarily by adipocytes, is a potential mediator of the BMI association because BMI and total body fat are positively associated with circulating leptin levels and leptin and its receptor are overexpressed in breast tumors. We conducted a prospective case–control study nested within the Nurses' Health Study II cohort examining the association between plasma leptin levels in premenopausal women and breast cancer risk. Leptin was measured in blood samples collected between 1996 and 1999. The analysis included 330 incident breast cancer cases diagnosed after blood collection and 636 matched controls. Logistic regression models, controlling for breast cancer risk factors, were used to calculate ORs and 95% CIs. After adjustment for BMI at age 18, weight change since age 18 to blood draw, and other breast cancer risk factors, plasma leptin levels were inversely associated with breast cancer risk (OR for top vs. bottom quartile = 0.55; 95% CI = 0.31–0.99; Ptrend = 0.04). Adjustment for BMI at blood draw attenuated the association (OR = 0.69; 95% CI = 0.38–1.23; Ptrend = 0.26). Our results suggest that leptin may be inversely associated with breast cancer risk, but it is unclear whether any part of this association is independent of BMI. Cancer Prev Res; 4(9); 1449–56. ©2011 AACR.Keywords
This publication has 49 references indexed in Scilit:
- Leptin and Soluble Leptin Receptor Levels in Plasma and Risk of Type 2 Diabetes in U.S. WomenDiabetes, 2009
- Leptin resistance: a prediposing factor for diet-induced obesityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Circulating levels of leptin, adiposity and breast cancer riskBritish Journal of Cancer, 2009
- The Roles of Serum Leptin Concentration and Polymorphism in Leptin Receptor Gene at Codon 109 in Breast CancerOncology, 2007
- Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young womenBreast Cancer Research and Treatment, 2006
- Leptin Expression in Breast Nipple Aspirate Fluid (NAF) and Serum is Influenced by Body Mass Index (BMI) but not by the Presence of Breast CancerHormone and Metabolic Research, 2004
- Modulation of Circulating Leptin Levels by Its Soluble ReceptorJournal of Biological Chemistry, 2001
- Presence of Leptin in Breast Cell Lines and Breast TumorsBiochemical and Biophysical Research Communications, 1999
- The role of oestrogens and progestagens in the epidemiology and prevention of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Percentage Points for a Generalized ESD Many-Outlier ProcedureTechnometrics, 1983